← Leaderboards
Harlan S. Robins
Adaptive Biotechnologies Corporation
$2,626,111
Attributed
$5,116,774
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2010–18$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$5,116,774 · 6
By mechanism
R01$3,149,732 · 1
R43$781,684 · 2
R21$421,080 · 1
R56$396,000 · 1
U19$368,278 · 1
Top collaborators
- Brent L Wood5 shared
- David Wu5 shared
- Robert J Livingston3 shared
Most similar at Adaptive Biotechnologies Corporation
Same institution · by research overlap
- Robert J Livingston$390,842
- Mark Rieder$266,199
Others in their field
Top investigators on “Technology”
- David Heimbrook · Leidos Biomedical Research, Inc.$995,338,451
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric S Lander · Whitehead Institute For Biomedical Res$606,570,095
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Richard K. Wilson · Washington University$441,856,657
Research focus
TechnologyT-LymphocyteBaseMeasurementDesignHigh-Throughput Nucleotide SequencingMolecularSamplingT-Cell Receptor GenesBlood SpecimenDiagnosticT-Cell ReceptorUnited StatesDiagnosisGoldCohortLaboratoriesAcuteUniversitiesBone MarrowCostComplexDeep SequencingClinically Significant
Grant awards (12)
Deep sequencing for minimal residual disease detection in Acute Lymphoblastic Leu$544,480
R01 · FY2018 · CA · contact PI
Deep sequencing for minimal residual disease detection in Acute Lymphoblastic Leu$648,389
R01 · FY2017 · CA · contact PI
TCR Sequencing Core$368,278
U19 · FY2017 · AI · contact PI
Deep sequencing for minimal residual disease detection in Acute Lymphoblastic Leu$648,389
R01 · FY2016 · CA · contact PI
Deep sequencing for minimal residual disease detection in Acute Lymphoblastic Leu$648,389
R01 · FY2015 · CA · contact PI
High-throughput sequencing of the T cell receptor in colorectal tumor infilt$191,400
R21 · FY2015 · CA · contact PI
Deep sequencing for minimal residual disease detection in Acute Lymphoblastic Leu$660,085
R01 · FY2014 · CA · contact PI
High-throughput sequencing of the T cell receptor in colorectal tumor infilt$229,680
R21 · FY2014 · CA · contact PI
Development of T-cell receptor repertoire profiling as a diagnostic for T1D$299,915
R43 · FY2011 · DK
Correlating TCR diversity to immune reconstitution after cord blood transplant$148,999
R43 · FY2011 · HL
Comprehensive Assessment of alpha/beta T-Cell Receptor Diversity$396,000
R56 · FY2010 · AI · contact PI
Development of T-cell receptor repertoire profiling as a diagnostic for T1D$332,770
R43 · FY2010 · DK